Treatment of taxol-resistant human tumor xenografts with metronomic 5-FU in combination with MTD paclitaxel reverses tumor drug resistance by down-regulating P-glycoprotein, a multidrug efflux transporter, and decreasing density of CAFs and collagen in the tumor microenvironment [214]. Here, ABCB1 is linked to neoplasm.